Recherche avancée

Timothy E. Guertin est membre du conseil d'administration de Teradyne, Inc., Acelity LP, Inc. et Varex Imaging Corp. et président du conseil de l'AeA NJ-PA, président de la division des systèmes de thérapie de la National Electrical Manufacturers Association, membre du conseil d'entreprise de l'American Society for Radiation Oncology, membre du conseil d'entreprise de l'Association canadienne de radio-oncologie et membre du conseil de la Californie du Nord. Dans sa carrière antérieure, M. Guertin a été vice-président de Varian Medical Systems, Inc. et président de Varian Medical Systems (une filiale de Varian Medical Systems, Inc.), président de TechAmerica, Inc. et trésorier et administrateur du Radiation Oncology Institute. Il a obtenu un diplôme de premier cycle à l'Université de Californie, Berkeley.

Daniel Guertin worked as a Research Analyst at Lehman Brothers, Inc. He then worked as a Principal at Sempra Energy Trading Corp.
in 2006.
In 2008, he worked as a Research Analyst at Barclays Capital, Inc. Mr. Guertin received his undergraduate degree from Purdue University in 1995 and his graduate degree from The Pennsylvania State University in 1997.

Denis Guertin is a member of the Canadian Association of Direct Response Insurers, where he currently works.
He previously worked as the President-Direct To Consumers Distribution at Intact Financial Corp., Senior Vice President at Belair Insurance Co., Inc., and President at The Corporation of Insurers of Damage.
He obtained his undergraduate degree from Université Laval in 1978.

Cindy Guertin currently works at The Center for Women & Families, Inc., as Director-Clinical Services.

Christine Guertin formerly worked at Millennium Pharmaceuticals, Inc., as Associate Director-Regulatory Affairs, Array BioPharma, Inc., as Director-Regulatory Affairs, Takeda Pharmaceuticals U.S.A., Inc., as Associate Director-Regulatory Affairs from 2007 to 2016, DUSA Pharmaceuticals, Inc., as Head-Regulatory Affairs from 2005 to 2007, Curis, Inc., as VP-Regulatory Affairs & Quality Assurance from 2019 to 2023, Genzyme Corp., as Regulatory Affairs Information Coordinator from 1999 to 2005, Altus Pharmaceuticals, Inc., as Head-Regulatory Affairs, and Synlogic, Inc., as Head-Regulatory Affairs from 2018 to 2019.
Ms. Guertin received her graduate degree from Regis College and undergraduate degree from Saint Joseph's College (Indiana).